The cost of diabetes in adults in Australia
MetadataShow full item record
Aims: To assess and compare costs associated with diabetes and lesser degrees of glucose intolerance in Australia. Methods: The Australian Diabetes, Obesity and Lifestyle study collected data on the use of health services and health related expenditure in 2004-2005. Complications data were collected through physical examination and biochemical tests or questionnaire. Data were available on 6101 participants. Age- and sex-adjusted direct healthcare costs, direct non-healthcare costs and government subsidies were estimated according to glucose tolerance status. Results: Annual direct per person costs were A$1898 for those with normal glucose tolerance to A$4390 for those with known diabetes. Costs were substantially higher in people with diabetes and both micro- and macrovascular complications. The total annual cost of diabetes in 2005 for Australians aged =30 years was A$10.6 billion (A$4.4 billion in direct costs; A$6.2 billion in government subsidies) which equates to A$14.6 billion in 2010 dollars. Total annual excess cost associated with diabetes in 2005 was A$4.5 billion (A$2.2 billion in direct costs; A$2.3 billion in government subsidies). Conclusion: The excess cost of diabetes to individuals and government is substantial and is greater in those with complications. Costs could potentially be reduced by preventing the development of diabetes or its complications.
Showing items related by title, author, creator and subject.
Determinants and costs of community nursing in patients with type 2 diabetes from a community-based observational study: The Fremantle Diabetes StudyDavis, W.; Lewin, Gill; Davis, T.; Bruce, D. (2013)Background: Despite widespread use, there is little information on the extent and impact of community nursing to patients with type 2 diabetes. Objective: To determine the incidence, predictors and costs of community ...
Cost-utility of angiotensin-converting enzyme inhibitor compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidityChowdhury, E.; Ademi, Z.; Moss, J.; Wing, L.; Reid, Christopher (2015)OBJECTIVE: To examine the cost-effectiveness of angiotensin-converting enzyme inhibitor-based (ACEI) treatment compared to thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as ...
Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as ComorbidityChowdhury, E.; Ademi, Z.; Moss, J.; Wing, L.; Reid, Christopher (2015)Abstract: The objective of this study was to examine the cost-effectiveness of angiotensin-converting enzyme inhibitor (ACEI)-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly ...